Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
19,963,692
-
Shares change
-
+681,080
-
Total reported value, excl. options
-
$1,336,584,283
-
Value change
-
+$48,405,121
-
Put/Call ratio
-
168%
-
Number of buys
-
107
-
Number of sells
-
93
-
Price
-
$66.95
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2025
As of 31 Mar 2025 ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) had 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,963,692 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Global Alpha Capital Management Ltd., CITADEL ADVISORS LLC, STATE STREET CORP, Deep Track Capital, LP, GOLDMAN SACHS GROUP INC, DIMENSIONAL FUND ADVISORS LP, and Ranger Investment Management, L.P..
This table shows 226 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.